Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers

Table 3 The number and proportions of diseases in the gastroscopy, colonoscopy and pathological examination groups

Examination	Disease	No.	%
Gastroscope (without pathological examination)	Esophagitis	2887	8.8%
	Esophageal erosion	88	0.3%
	Esophageal ulcer	30	0.1%
	Esophageal protuberant lesion	491	1.5%
	Esophageal non-protuberant lesion	77	0.2%
	Barrett’s esophagus	66	0.2%
	Bile reflux	1344	4.1%
	Gastric atrophy	45	0.1%
	Gastric erosion	12457	37.9%
	Gastric hemorrhage	1117	3.4%
	Gastric ulcer	1088	3.3%
	Gastric protuberant lesion	3329	10.1%
	Gastric non-protuberant lesion	225	0.7%
	Duodenitis	1473	4.5%
	Duodenal erosion	26	0.1%
	Duodenal ulcer	1548	4.7%
	Duodenal protuberant lesion	666	2.0%
	Duodenal non-protuberant lesion	31	0.1%
Colonoscopy (without pathological examination)	Colorectitis	653	2.0%
	Colorectal erosion	29	0.1%
	Colorectal ulcer	99	0.3%
	Colorectal protuberant lesion	7312	22.3%
	Colorectal non-protuberant lesion	36	0.1%
Pathological examination	Esophageal mucositis	398	1.2%
	Esophageal dysplasia	44	0.1%
	Esophageal adenoma	1	< 0.1%
	Esophageal hyperplastic polyp	2	< 0.1%
	Esophageal glandular hyperplasia	4	< 0.1%
	Chronic atrophic gastritis	1809	5.5%
	Gastric dysplasia	308	0.9%
	Gastric adenoma	13	< 0.1%
	Gastric hyperplastic polyps	117	0.4%
	Gastric glandular hyperplasia	761	2.3%
	Gastric juvenile polyps	1	< 0.1%
	Duodenal mucositis	276	0.8%
	Duodenal dysplasia	24	0.1%
	Duodenal adenoma	12	< 0.1%
	Duodenal hyperplastic polyps	10	< 0.1%
	Duodenal gland hyperplasia	31	0.1%
	Colorectal mucositis	2206	6.7%
	Colorectal high-grade intraepithelial neoplasia	330	1.0%
	Colorectal low-grade intraepithelial neoplasia	3364	10.2%
	Colorectal adenoma	3707	11.3%
	Colorectal hyperplastic polyps	1037	3.2%
	Colorectal inflammatory polyps	13	< 0.1%
	Colorectal gland hyperplasia	567	1.7%
	Colorectal juvenile polyps	3	< 0.1%
	Peutz-Jeghers polyps	5	< 0.1%
	Familial polyposis coli	3	< 0.1%
	Esophageal cancer	57	0.2%
	Gastric cancer	392	1.2%
	Duodenal cancer	25	0.1%
	Small intestine cancer	4	< 0.1%
	Colorectal cancer	892	2.7%
	Liver cancer	127	0.4%
	Pancreatic cancer	47	0.1%
	Gallbladder cancer	20	0.1%
	Bile duct cancer & ampulla cancer	10	< 0.1%
	Lung cancer	129	0.4%
	Breast cancer	55	0.2%
	Ovarian cancer	57	0.2%
	Uterine malignancy	28	0.1%
	Kidney cancer	37	0.1%
	Prostate cancer	28	0.1%
	Bladder Cancer	17	0.1%
	Leukemia	1	< 0.1%
	Lymphoma	29	0.1%
	Other malignant tumors	15	< 0.1%